MARKET

ACHV

ACHV

Achieve Life Sciences Inc
NASDAQ
4.250
+0.300
+7.59%
After Hours: 4.260 +0.01 +0.24% 19:48 02/06 EST
OPEN
4.100
PREV CLOSE
3.950
HIGH
4.270
LOW
3.975
VOLUME
576.12K
TURNOVER
--
52 WEEK HIGH
6.03
52 WEEK LOW
1.840
MARKET CAP
226.24M
P/E (TTM)
-3.0851
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Roivant Sciences (ROIV)
TipRanks · 1d ago
H.C. Wainwright says Chantix news ‘significant win’ for Achieve Life Sciences
TipRanks · 1d ago
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch
Seeking Alpha · 2d ago
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy
Seeking Alpha · 3d ago
Weekly Report: what happened at ACHV last week (0126-0130)?
Weekly Report · 5d ago
Achieve Life Sciences Grants Stock Options to New Employees Under 2024 Equity Inducement Plan
Reuters · 01/30 21:05
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Barchart · 01/30 15:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 01/28 21:05
More
About ACHV
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company. The Company focuses on addressing the global smoking health and nicotine dependence epidemic through the development and commercialization of cytisinicline. It has completed two Phase III studies with cytisinicline for smoking cessation and one Phase II study with cytisinicline in vaping cessation. Cytisinicline is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a dual-acting mechanism of action, being both a receptor agonist and antagonist. Cytisinicline is an investigational product candidate being developed for the treatment of nicotine dependence and has not been approved by the Food and Drug Administration for any indication in the United States. Cytisinicline acts as a partial agonist/antagonist, binding to alpha-4 beta-2 nicotinic receptors in the brain and is thought to have two potential consequences in treating nicotine dependence.

Webull offers Achieve Life Sciences Inc stock information, including NASDAQ: ACHV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACHV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACHV stock methods without spending real money on the virtual paper trading platform.